Ingevity (NGVT) Cost of Revenue (2015 - 2026)

Ingevity (NGVT) has 12 years of Cost of Revenue data on file, last reported at $141.6 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 4.12% year-over-year to $141.6 million in Q1 2026; TTM through Mar 2026 was $735.3 million, a 4.38% decrease from a year earlier, with the FY2025 full-year figure at $706.1 million, down 3.97% from the prior year.
• Cost of Revenue for Q1 2026 stood at $141.6 million, down from $167.3 million in the prior quarter.
• Over the last five years, Cost of Revenue for NGVT reached as high as $328.8 million in Q2 2023 and fell as low as -$137.5 million in Q4 2023.
• Historically, Cost of Revenue has averaged $212.6 million across 5 years, with a median of $240.4 million in 2024.
• Across the five-year window, Cost of Revenue sank 149.42% in 2023 and soared 218.84% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $278.2 million in 2022, then sank by 149.42% to -$137.5 million in 2023, then surged by 218.84% to $163.4 million in 2024, then gained by 2.39% to $167.3 million in 2025, then fell by 15.36% to $141.6 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $141.6 million in Q1 2026, $167.3 million in Q4 2025, and $199.2 million in Q3 2025.